ArticleBMC cancer2023

LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study.

Ken Arimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.